Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium†
Jonine D. Figueroa, Peter Schürmann(Hannover Re (Germany)), Nichola Johnson(Institute of Cancer Research), Volker Arndt(German Cancer Research Center), Marjanka K. Schmidt(University of Cambridge), Reiner Strick(Friedrich-Alexander-Universität Erlangen-Nürnberg), Hiltrud Brauch(German Cancer Research Center), Thomas Brüning(Institute for Prevention and Occupational Medicine), Julian Peto(London School of Hygiene & Tropical Medicine), Peter A. Fasching(Universitätsklinikum Erlangen), Jenny Chang‐Claude(Universität Hamburg), Clare Turnbull(Institute of Cancer Research), Thilo Dörk(Hannover Re (Germany)), Michael J. Kerin(Ollscoil na Gaillimhe – University of Galway), Annegien Broeks, Rob A.�E.�M. Tollenaar(Leiden University Medical Center), Ian Tomlinson(University of Oxford), Roger L. Milne(The University of Melbourne), José Ignacio Arias(Spanish National Cancer Research Centre), Arif B. Ekici(University Medical Center Groningen), Javier Benı́tez(Spanish National Cancer Research Centre), F. Marmé(Heidelberg University), Henrik Flyger(University of Copenhagen), Christina Justenhoven(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Elinor J. Sawyer(King's College London), Heiko Müller(Munich Leukemia Laboratory (Germany)), Olivia Fletcher(Breast Cancer Care), Stig E. Bojesen(University of Copenhagen), Montserrat García‐Closas(Institute of Cancer Research), M. Pilar Zamora(Universidad Autónoma de Madrid), Hermann Brenner(Universidad de Granada), Børge G. Nordestgaard(Gentofte Hospital), Christof Sohn, Manjeet K. Humphreys(University of Cambridge), Andreas Schneeweiß(German Cancer Research Center), Melissa C. Southey(The University of Melbourne), Nazneen Rahman(Institute of Cancer Research), Shan Wang‐Gohrke(Universität Ulm), Barbara Burwinkel(German Cancer Research Center), Matthias W. Beckmann, Anthony Renwick(Institute of Cancer Research), John L. Hopper(The University of Melbourne), Sheila Seal(Institute of Cancer Research), Radka Platte(University of Cambridge), Rebecca Hein(Technical University of Munich), Laura J. van’t Veer(University of California, San Francisco), Isabel dos‐Santos‐Silva(London School of Hygiene & Tropical Medicine), Carmel Apicella(The University of Melbourne), Fleur Hammet(Monash Health)
Cited by 80
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k